mbi-logombi-logombi-logo-mobilembi-logo-mobile
  • Home
  • Agriculture
  • Business
  • Energy & Mining
  • Food
  • Healthcare
  • MPR News
  • National News
  • Retail
  • Tourism
✕
Minnesota COVID-19 deaths jump by 29, worst toll since June
October 14, 2020
Jones: Tuberville charity filings raise questions
October 14, 2020

US regulators approve 1st treatment for Ebola

U.S. regulators Wednesday approved the first drug for the treatment of Ebola.

The Food and Drug Administration OK’d the drug developed by Regeneron Pharmaceuticals for treating adults and children. It was tested during an outbreak in Congo that killed nearly 2,300 people before it ended in June.

The drug, named Inmazeb (IN’-meh-zehb), dramatically increased survival in study participants, compared to three other treatments. The study was ended ahead of schedule last year so patients could get Inmazeb or a second drug that was nearly as effective.

Regeneron’s treatment is a combination of three antibodies that work by killing the virus.

Seeking U.S. approval first is a common strategy for drugmakers developing treatments for diseases mainly found in the tropics and in developing countries.

The FDA’s action will make it easier for Regeneron to get approval or allow emergency use during outbreaks in African countries, where the approval process is not straightforward, said Leah Lipsich, who heads Regeneron’s global program for infectious diseases.

The U.S. government, which helped fund the drug’s development, will buy thousands of doses over the next six years to go into the Strategic National Stockpile. Ebola cases are rare in the U.S., but occasionally are diagnosed in travelers returning from areas with an outbreak.

The FDA approved the first vaccine for Ebola in last December.

Share

Related posts

March 24, 2023

Minnesota lawmakers likely to spend $100 million on broadband. How far will that go?


Read more
March 24, 2023

Settlement will wipe $6 billion in student loan debt — but not for these borrowers


Read more
March 21, 2023

Lawmakers consider influx of cash for Minnesota cities, counties facing inflation


Read more
✕

CATEGORIES

  • Agriculture
  • Announcements
  • Business
  • Business Focus
  • Energy & Mining
  • Featured
  • Food
  • Healthcare
  • MPR News
  • National News
  • Retail
  • Technology
  • Tourism

OUR MAGAZINE

Minnesota Business Insights is the premiere business web, digital and print media publication, built for entrepreneurs, visionaries, builders, and doers who are committed to growing the economy of the great state of Minnesota.

LATEST POSTS

  • Credit Suisse's top execs could face a probe over their role in the banking giant's collapse, Swiss watchdog says
    March 27, 2023
  • An Amazon driver went viral on TikTok after delivering a package during a police standoff with an armed suspect
    March 27, 2023

ADVERT

© 2020 Minnesota Business Insights. All Rights Reserved.